Mr. Marvin A. Eberling, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 119 N Main St, Plentywood, MT 59254 Phone: 406-765-1810 Fax: 406-765-1811 |
Kristen Kiemele Berntson, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 119 N Main St, Plentywood, MT 59254 Phone: 406-765-1810 Fax: 406-765-1811 |
Mrs. Kathryn M Eberling, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 119 N Main St, Plentywood, MT 59254 Phone: 406-765-1810 Fax: 406-765-1811 |
Kirsten Tryan, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 119 N Main St, Plentywood, MT 59254 Phone: 406-765-1810 |
Mr. Robert Conway Mann Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 119 N Main St, Plentywood, MT 59254 Phone: 406-765-1810 |
News Archive
Obsidian Therapeutics, Inc., a biotechnology company dedicated to the development of next-generation cell and gene therapies with pharmacologic operating systems, today announced that the company presented preclinical data on its regulated IL12 and IL15 programs at the Annual Meeting of the American Society of Gene and Cell Therapy in Chicago, IL.
Postmenopausal women who have higher testosterone levels may be at greater risk of heart disease, insulin resistance and the metabolic syndrome compared to women with lower testosterone levels, according to a new study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
What makes the coronavirus disease (COVID-19) global pandemic different from the Spanish flu in 1918? In 1918, transportation, technology, and science were in their infancy, with the medical field not capable of fighting outbreaks. Technology has come a long way, within days, scientists have already identified the type of virus spreading in China, and three months after, vaccine trials have started.
Researchers at Duke University conducted a randomized clinical trial in patients with subarachnoid hemorrhage (SAH). In this study, the researchers compared two approaches to intracranial pressure management-continuous and intermittent drainage of cerebrospinal fluid (CSF)-and outcomes associated with those methods, focusing specifically on the incidence of cerebral vasospasm.
› Verified 9 days ago